4-Pyridinecarbonitrile, 3-[(tetrahydro-3-furanyl)oxy]-

Catalog No. :
ACGPND716
CAS No. :
1509582-17-5
Molecular Formula :
C10H10N2O2
Molecular Weight :
190.20

IUPAC Name:3-((tetrahydrofuran-3-yl)oxy)isonicotinonitrile

4-Pyridinecarbonitrile, 3-[(tetrahydro-3-furanyl)oxy]- structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$507.00Login to see priceInquiryInquiry
1g97%$1607.00Login to see priceInquiryInquiry
5g97%$4821.00Login to see priceInquiryInquiry
10g97%$6755.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Pyridinecarbonitrile, 3-[(tetrahydro-3-furanyl)oxy]-
IUPAC Name3-((tetrahydrofuran-3-yl)oxy)isonicotinonitrile
Molecular FormulaC10H10N2O2
Molecular Weight190.20
SMILESN#CC1=C(OC2COCC2)C=NC=C1
InChI KeyPQJCRTURVVFERZ-UHFFFAOYSA-N
Synonym3-((tetrahydrofuran-3-yl)oxy)isonicotinonitrile;4-Pyridinecarbonitrile, 3-[(tetrahydro-3-furanyl)oxy]-
CAS No.1509582-17-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACGPND716 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQWUO346 route compound structure diagram
    ACQWUO346113770-88-0 In Stock
  2. Plus
  3. ACHJGS164 route compound structure diagram
    ACHJGS164453-20-3 In Stock
  4. Then
  5. ACGPND716 route product structure diagram
    ACGPND7161509582-17-5
Inquiry

2. ACGPND716 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKQRD215 route compound structure diagram
    ACKQRD21568325-15-5 In Stock
  2. Plus
  3. ACHJGS164 route compound structure diagram
    ACHJGS164453-20-3 In Stock
  4. Then
  5. ACGPND716 route product structure diagram
    ACGPND7161509582-17-5
Inquiry

Comments (0)